Physician profile
Rosane Nunes
NPI 1295179323
$1,815.50
in general payments reported to CMS, 2019-2025
12 companies · $18.08 in 2025
The $18.08 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $374 · 2021: $331 · 2022: $205 · 2023: $462 · 2024: $15.94 · 2025: $18.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $665.48 | 2019-2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $419.24 | 2019-2021 | |
| Amarin Pharma, INC. | $122.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $115.00 | 2019 | |
| Lilly USA, LLC | $114.48 | 2020-2023 | Mounjaro |
| Amgen INC. | $93.77 | 2023-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $92.51 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.03 | 2019-2023 | Synjardy, Jardiance |
| Merz North America, INC. | $51.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $36.75 | 2019-2023 | Seglentis |
| Abbvie INC. | $34.92 | 2023-2024 | |
| Biosense Webster, INC. | $17.03 | 2023 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosane Nunes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.